Verified Nov 2026
Other
·
Atlanta, Georgia
·
Since 1997
ZOLL Itamar is a sleep apnea diagnostics company headquartered in Atlanta, Georgia, with operations in Caesarea, Israel, and other locations. Founded in 1997, it employs roughly 200 to 500 people and has an estimated annual revenue of $50 to $100 million. The company was acquired by ZOLL Medical Corporation in December 2021 and operates as a division of it. It serves medical customers, with products built around peripheral arterial tone (PAT) signal technology for non-invasive home sleep testing. Its recent development includes FDA clearance for new PolySense accessories for the WatchPAT 400 device.
Zoll Itamar at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
1997
Headquarters
Atlanta, Georgia
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
ZOLL Itamar is a sleep apnea diagnostics company headquartered in Atlanta, Georgia, with operations in Caesarea, Israel, and other locations. Founded in 1997, it employs roughly 200 to 500 people and has an estimated annual revenue of $50 to $100 million. The company was acquired by ZOLL Medical Corporation in December 2021 and operates as a division of it. It serves medical customers, with products built around peripheral arterial tone (PAT) signal technology for non-invasive home sleep testing. Its recent development includes FDA clearance for new PolySense accessories for the WatchPAT 400 device.
At a glance
Attribute | Detail |
|---|---|
Founded | 1997 |
Headquarters | Atlanta, Georgia |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
What Zoll Itamar makes
The company's products include the WatchPAT series for at-home sleep apnea testing and the EndoPAT device for assessing cardiovascular health, and it received CE approval for an arrhythmia detection feature in January 2025.
Latest developments
2026-11-02 — New PolySense™ Accessories for WatchPAT® 400 Receive FDA Clearance (tmcnet.com)
2026-01-03 — We are proud to announce a strategic partnership between Medworks and ZOLL Itamar Medical by ZOLL, bringing WatchPAT™ Home Sleep Apnea Testing to the United Arab Emirates 🇦🇪 | Medworks Medical (linkedin.com)
2025-05-28 — End of Sales Notice for EndoPAT 2000 and EndoPAT X - ZOLL Itamar (itamar-medical.com)
2025-01-29 — 🚀Exciting news! 🚀 We are thrilled to announce that we received CE approval for the Arrhythmia Detection feature. | ZOLL Itamar (linkedin.com)
Company details
The company is a division of ZOLL Medical Corporation, which acquired it in December 2021, and its revenue band is an estimate rather than a reported figure. Zoll Itamar was founded in 1997, has an estimated 200-500 employees, and is headquartered in Atlanta, Georgia.
Frequently asked questions
What does Zoll Itamar do?
ZOLL Itamar is a sleep apnea diagnostics company headquartered in Atlanta, Georgia, with operations in Caesarea, Israel, and other locations. Founded in 1997, it employs roughly 200 to 500 people and has an estimated annual revenue of $50 to $100 million. The company was acquired by ZOLL Medical Corporation in December 2021 and operates as a division of it. It serves medical customers, with products built around peripheral arterial tone (PAT) signal technology for non-invasive home sleep testing. Its recent development includes FDA clearance for new PolySense accessories for the WatchPAT 400 device.
Where is Zoll Itamar headquartered?
Zoll Itamar is headquartered in Atlanta, Georgia (3290 Cumberland Club Dr SE, Atlanta, Georgia, 30339-4901).
When was Zoll Itamar founded?
Zoll Itamar was founded in 1997.
How big is Zoll Itamar?
Zoll Itamar has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.